# Catalent expands biologics manufacturing operations in Bloomington, Indiana

Catalent commenced a significant expansion of its biologics manufacturing operations in Bloomington, Indiana, with plans to create up to 200 new jobs by 2024 and invest over $100 million, including $14 million for packaging expansion.

- Type: Expansion
- Announced: 2019-01-07
- Where: Bloomington, Indiana, United States
- Value: $100.0M
- Jobs: 200
- Starts operating: Apr 2019
- Status: under construction
- Products: biologics, drug substance, drug product fill/finish, packaging
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Catalent](https://endata.com/companies/36530.md)

## Sources

- [iedc.in.gov](https://iedc.in.gov/events/news/details/2019/01/07/catalent), 2019-01-07: "Catalent plans to invest over $100 million in its Bloomington operations, growing the site’s packaging capabilities and manufacturing capacity to support customers’ clinical pipeline and commercial launches."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.